Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/29/2019
Boehringer Ingelheim Launches First Swine Vaccines Produced in China
1/28/2019
Advent International Makes Majority Investment in CRO Bioduro
1/18/2019
MabPlex's Manufactured mAb Receives IND Approval from the U.S. FDA
1/17/2019
Boehringer Ingelheim Expands Biopharma Commercial Manufacturing in Chi...
1/8/2019
CANbridge Pharma and WuXi Biologics Expand Rare Disease Therapeutics P...
12/10/2018
WuXi AppTec Expands Site in California for Pharmaceutical R&D ...
12/5/2018
Changzhou Qianhong Biopharma Expands Facility for Polysaccharides and ...
12/5/2018
Wuxi AppTec Says US Hurdles Will Not Dim Acquisition Appetite
11/29/2018
WuXi Biologics and ABL Enter Development and Clinical Manufacturing Pa...
11/29/2018
Datwyler to Enter China to Meet Needs for Injectable Drug Components
11/27/2018
WuXi Biologics Begins Construction of A Major Biologics Center in Shan...
11/7/2018
GE to Produce Single-Use Consumables in China thru Collaboration with ...
10/25/2018
WuXi AppTec Launches Drug Screening Library
9/27/2018
PharmaBlock Acquires Manufacturing Facility in China
9/20/2018
Wuxi AppTech Submitted $1B+ IPO Application in Hong Kong
9/11/2018
WuXi Biologics and Inhibrx Enter an Exclusive Partnership for GMP Manu...
9/11/2018
China CDMO Market 2018-2021: The R&D Cost of New Drugs Continues t...
9/3/2018
Boehringer Teams Up with Tsinghua University for Joint R&D in Immu...
9/3/2018
Boehringer Supports BeiGene in Its China NDA Submission for Tislelizum...
7/25/2018
WuXi STA's Jinshan API Plant Passes 4th U.S. FDA Inspection
7/20/2018
WuXi STA and Antengene Sign Development and Manufacturing Agreement
7/18/2018
New Report: China's CDMO Market to Boom by 2021
7/4/2018
Boehringer Ingelheim Extends "One-Stop-Shop" Service with Ne...
6/25/2018
WuXi Biologics and Harbour BioMed Announce Strategic Partnership
6/20/2018
Wuxi Biologics Initiated Construction of Integrated ADC Solution Cente...
6/12/2018
Chinese Government Launch Support Program for Biopharma CRO and CMO Se...
6/11/2018
WuXi Biologics to Build a $60M Biologics Facility in the U.S.
6/5/2018
Sinobioway Biomedicine to Invest Nearly $500M in Massive Biologics Sit...
5/31/2018
FORMA Therapeutics and HitGen Initiate Multiyear Research Collaboratio...
5/29/2018
WuXi To Build Biologics Center In Northern China
Page:
9
/
19
Total number of articles:
545
:
[First]
[<<]
[7]
[8]
[9]
[10]
[11]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit